Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniele Fanale

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
PPAR Research|May 23, 2017
The Interplay between Metabolism, PPAR Signaling Pathway, and CancerDaniele Fanale, Valeria Amodeo, Stefano Caruso
Advances in Experimental Medicine and Biology|September 28, 2018
Circular RNA in ExosomesDaniele Fanale, Simona Taverna, Antonio Russo, et al.
Advances in Experimental Medicine and Biology|August 31, 2016
Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal CancerDaniele Fanale, Marta Castiglia, Viviana Bazan, et al.
Advances in Experimental Medicine and Biology|August 31, 2016
Non-coding RNAs Functioning in Colorectal Cancer Stem CellsDaniele Fanale, Nadia Barraco, Angela Listì, et al.
Journal of Cancer Research and Therapeutics|September 2, 2017
Comment on: Survey of cervical cancer survivors regarding quality of life and sexual functionAntonio Simone Laganà, Valentina Lucia La Rosa, Daniele Fanale, et al.
Molecular Cancer|August 6, 2010
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repairMario Federico, Catherine E Symonds, Luigi Bagella, et al.
Expert Opinion on Drug Safety|November 21, 2018
Monoclonal antibodies for the treatment of non-hematological tumors: a safety reviewLidia Rita Corsini, Daniele Fanale, Francesco Passiglia, et al.
Oncotarget|August 17, 2018
Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinomaMaría Inés Molejon, Mirna Swayden, Daniele Fanale, et al.
Expert Opinion on Emerging Drugs|January 28, 2010
Anti-endothelin drugs in solid tumorsAntonio Russo, Giuseppe Bronte, Sergio Rizzo, et al.
PPAR Research|February 10, 2017
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling PathwayLaura La Paglia, Angela Listì, Stefano Caruso, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
PPAR Research|May 23, 2017
The Interplay between Metabolism, PPAR Signaling Pathway, and CancerDaniele Fanale, Valeria Amodeo, Stefano Caruso
Advances in Experimental Medicine and Biology|September 28, 2018
Circular RNA in ExosomesDaniele Fanale, Simona Taverna, Antonio Russo, et al.
Advances in Experimental Medicine and Biology|August 31, 2016
Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal CancerDaniele Fanale, Marta Castiglia, Viviana Bazan, et al.
Advances in Experimental Medicine and Biology|August 31, 2016
Non-coding RNAs Functioning in Colorectal Cancer Stem CellsDaniele Fanale, Nadia Barraco, Angela Listì, et al.
Journal of Cancer Research and Therapeutics|September 2, 2017
Comment on: Survey of cervical cancer survivors regarding quality of life and sexual functionAntonio Simone Laganà, Valentina Lucia La Rosa, Daniele Fanale, et al.
Molecular Cancer|August 6, 2010
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repairMario Federico, Catherine E Symonds, Luigi Bagella, et al.
Expert Opinion on Drug Safety|November 21, 2018
Monoclonal antibodies for the treatment of non-hematological tumors: a safety reviewLidia Rita Corsini, Daniele Fanale, Francesco Passiglia, et al.
Oncotarget|August 17, 2018
Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinomaMaría Inés Molejon, Mirna Swayden, Daniele Fanale, et al.
Expert Opinion on Emerging Drugs|January 28, 2010
Anti-endothelin drugs in solid tumorsAntonio Russo, Giuseppe Bronte, Sergio Rizzo, et al.
PPAR Research|February 10, 2017
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling PathwayLaura La Paglia, Angela Listì, Stefano Caruso, et al.
Pageof 7